S&P 500

5.631,22

0,28%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Avid Bioservices Inc (CDMOP)
Avid Bioservices Inc (CDMOP) Notícias

CDMOP

Avid Bioservices (CDMOP)

Avid Bioservices Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP

<< Anterior 1 2 3 4 5 6 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
29/05/2018	09:05	GlobeNewswire Inc.	Avid Bioservices to Participate at BIO International Convention 2018	NASDAQ:CDMOP	Avid Bioservices Inc
08/05/2018	09:05	GlobeNewswire Inc.	Avid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process Sciences	NASDAQ:CDMOP	Avid Bioservices Inc
24/04/2018	09:05	GlobeNewswire Inc.	Avid Bioservices Provides Update on Ongoing Expansion of Process Development Capabilities and Laboratory Infrastructure	NASDAQ:CDMOP	Avid Bioservices Inc
17/04/2018	17:14	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:CDMOP	Avid Bioservices Inc
09/04/2018	09:05	GlobeNewswire Inc.	Avid Bioservices to Participate at INTERPHEX 2018	NASDAQ:CDMOP	Avid Bioservices Inc
22/03/2018	09:05	GlobeNewswire Inc.	Avid Bioservices Receives Six 2018 CMO Leadership Awards	NASDAQ:CDMOP	Avid Bioservices Inc
13/03/2018	17:40	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CDMOP	Avid Bioservices Inc
13/03/2018	09:05	GlobeNewswire Inc.	Avid Bioservices to Participate at Upcoming CDMO Industry Conferences	NASDAQ:CDMOP	Avid Bioservices Inc
12/03/2018	17:41	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CDMOP	Avid Bioservices Inc
12/03/2018	17:05	GlobeNewswire Inc.	Avid Bioservices Reports Financial Results for Third Quarter of Fiscal Year 2018 and Recent Developments	NASDAQ:CDMOP	Avid Bioservices Inc
07/03/2018	18:05	GlobeNewswire Inc.	Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock	NASDAQ:CDMOP	Avid Bioservices Inc
06/03/2018	10:05	GlobeNewswire Inc.	Avid Bioservices to Present at the 30th Annual ROTH Conference	NASDAQ:CDMOP	Avid Bioservices Inc
05/03/2018	10:05	GlobeNewswire Inc.	Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2018 After Market Close on March 12, 2018	NASDAQ:CDMOP	Avid Bioservices Inc
26/02/2018	10:05	GlobeNewswire Inc.	Avid Bioservices Announces Resignation of Chief Financial Officer	NASDAQ:CDMOP	Avid Bioservices Inc
21/02/2018	10:05	GlobeNewswire Inc.	Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roi...	NASDAQ:CDMOP	Avid Bioservices Inc
20/02/2018	18:05	GlobeNewswire Inc.	Avid Bioservices Announces Closing of Public Offering of Common Stock	NASDAQ:CDMOP	Avid Bioservices Inc
15/02/2018	08:00	GlobeNewswire Inc.	Avid Bioservices Announces Pricing of Public Offering of Common Stock	NASDAQ:CDMOP	Avid Bioservices Inc
14/02/2018	19:02	GlobeNewswire Inc.	Avid Bioservices Announces Proposed Offering of Common Stock	NASDAQ:CDMOP	Avid Bioservices Inc
12/02/2018	11:05	GlobeNewswire Inc.	Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including...	NASDAQ:CDMOP	Avid Bioservices Inc
23/01/2018	11:05	GlobeNewswire Inc.	Avid Bioservices to Present at NobleCon14	NASDAQ:CDMOP	Avid Bioservices Inc
05/01/2018	11:05	GlobeNewswire Inc.	Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development a...	NASDAQ:CDMOP	Avid Bioservices Inc
02/01/2018	11:05	GlobeNewswire Inc.	Peregrine Pharmaceuticals to Present at Biotech Showcase 2018	NASDAQ:CDMOP	Avid Bioservices Inc
26/12/2017	11:05	GlobeNewswire Inc.	Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive Officer	NASDAQ:CDMOP	Avid Bioservices Inc
11/12/2017	19:05	GlobeNewswire Inc.	Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent Developments	NASDAQ:CDMOP	Avid Bioservices Inc
07/12/2017	19:58	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CDMOP	Avid Bioservices Inc
07/12/2017	19:57	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CDMOP	Avid Bioservices Inc
07/12/2017	19:05	GlobeNewswire Inc.	Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock	NASDAQ:CDMOP	Avid Bioservices Inc
04/12/2017	19:05	GlobeNewswire Inc.	Peregrine Pharmaceuticals to Report Financial Results for Second Quarter of Fiscal Year 2018 After Market Close on December 1...	NASDAQ:CDMOP	Avid Bioservices Inc
29/11/2017	11:05	GlobeNewswire Inc.	Avid Bioservices Announces Appointment of Tracy Kinjerski as Vice President of Business Operations	NASDAQ:CDMOP	Avid Bioservices Inc
28/11/2017	11:05	GlobeNewswire Inc.	Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement	NASDAQ:CDMOP	Avid Bioservices Inc